Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03118050 · ClinicalTrials.gov registry record · NA
Identifying Therapeutic Targets of Accelerated Sarcopenia
A NA study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT03118050 is a NA study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 95 participants.
The verdict
NCT03118050, a NA study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
The proposed research is designed to identify the mechanisms that can accelerate loss of muscle size, strength and physical function in type 2 diabetes and with hospitalization in older persons. About ⅓ of older Americans have type 2 diabetes, and about ⅓ of the hospitalizations in the USA involve persons older than 65 year of age. The proposed research is relevant to the part of NIH's mission that pertains to development of the fundamental knowledge that will improve health and reduce the burdens of disability, because this work will provide the fundamental evidence to identify new targets for the development of innovative treatments to slow down muscle loss and disability in our aging society.
Interventions
- BEHAVIORAL Bed rest
- BEHAVIORAL Resistance exercise training
- BEHAVIORAL Intensive physical therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2017-05-28 |
| Est. Completion | 2023-08-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03118050
The ClinicalTrials.gov registry entry for NCT03118050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bed rest is the first listed.
NCT03118050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03118050 about?
NCT03118050 is a clinical study titled "Identifying Therapeutic Targets of Accelerated Sarcopenia". The proposed research is designed to identify the mechanisms that can accelerate loss of muscle size, strength and physical function in type 2 diabetes and with hospitalization in older persons. About ⅓ of older Americans have type 2 diabetes, and about ⅓ of the hospitalizations in the USA involve p...
What is the current status of trial NCT03118050?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2017-05-28. Estimated completion is 2023-08-21.
What interventions are being tested in trial NCT03118050?
The interventions under investigation include: Bed rest (BEHAVIORAL), Resistance exercise training (BEHAVIORAL), Intensive physical therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03118050?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.